市場調查報告書
商品編碼
1467909
2024-2032 年按產品類型(Guglielmi 可拆卸線圈、矩陣線圈)、適應症、應用、最終用戶(醫院、門診手術中心、中風中心等)和地區分類的神經血管線圈市場報告Neuroendovascular Coil Market Report by Product Type (Guglielmi Detachable Coils, Matrix Coils), Indication, Application, End User (Hospitals, Ambulatory Surgical Centers, Stroke Centers, and Others), and Region 2024-2032 |
IMARC Group年,全球神經血管內彈簧圈市場規模達9.999億美元。
神經血管內彈簧圈栓塞是一種微創血管內治療,用於阻斷腦血管中的血流。治療動脈瘤至關重要,動脈瘤是由血管壁薄弱引起的隆起,它可能因壓力升高而破裂並流入大腦。動脈瘤破裂的症狀通常包括突然發作的嚴重頭痛、噁心、嘔吐、視力模糊或複視、癲癇發作。在神經血管內彈簧圈栓塞中,外科醫師用可拆卸的鉑金彈簧圈緊緊包裹動脈瘤,以促進血液凝固並降低外壁的壓力。神經血管內彈簧圈栓塞在全球範圍內變得越來越流行,因為它的成本較低並降低了患者的風險。
神經血管內線圈技術在形狀、長度和生物活性方面取得了一些進展。除此之外,顱內支架在改善其部署和輸送方面也取得了重大進展。外科醫生已開始將顱內支架與線圈技術相結合,以治療動脈瘤並減少與復發相關的問題。此外,在術後併發症、良好的結果和復健方面,血管內彈簧圈栓塞被認為是比夾閉術更好的手術技術。除此之外,各個市場參與者都在投資引進技術先進的產品。例如,2018 年,強生醫療器材公司旗下的 Cerenovus 推出了 Galaxy G3 Mini 栓塞彈簧圈,該彈簧圈設計為不規則形狀,使該裝置能夠填充腦動脈瘤中的開放空間。
IMARC 集團的最新報告深入洞察了全球神經血管內彈簧圈市場,涵蓋了其所有重要方面。內容涵蓋從宏觀市場概況到微觀細節的行業表現、近期趨勢、關鍵市場促進因素和挑戰、SWOT分析、波特五力分析、價值鏈分析等。 、研究人員、顧問、商業策略家以及所有擁有任何利益或計劃以任何方式進軍神經血管內線圈市場的人。
The global neuroendovascular coil market size reached US$ 999.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,260.9 Million by 2032, exhibiting a growth rate (CAGR) of 2.5% during 2024-2032.
Neuroendovascular coiling is a minimally invasive endovascular treatment which is performed to block the blood flow in a blood vessel in the brain. It is essential to treat an aneurysm, a bulge caused by weakness in the wall of a blood vessel, which can rupture due to rising pressure and bleed into the brain. The symptoms of a ruptured aneurysm generally include sudden onset of a severe headache, nausea, vomiting, blurred or double vision, and seizure. In neuroendovascular coiling, a surgeon tightly packs the aneurysm with detachable platinum coils that promote blood clotting and reduce pressure on the outer wall. Neuroendovascular coiling is becoming popular across the globe as it incurs less cost and lowers the risk for the patients.
Several advances have been made in the neuroendovascular coil technology in terms of shape, length and bioactivity. Besides this, significant progress has been made in intracranial stents to improve their deployment and delivery. Surgeons have started integrating intracranial stents with the coil technology to treat aneurysms and reduce issues related to recurrence. Moreover, endovascular coiling is being considered a better surgical technique than clipping regarding postoperative complications, favorable outcomes and rehabilitation. Other than this, various market players are investing in the introduction of technologically advanced products. For instance, in 2018, Cerenovus, a division of the Johnson & Johnson Medical Devices Companies, launched the Galaxy G3 Mini embolic coil which is designed to have an irregular shape to enable the device to fill open spaces in cerebral aneurysms.
IMARC Group's latest report provides a deep insight into the global neuroendovascular coil market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the neuroendovascular coil market in any manner.
IMARC Group provides an analysis of the key trends in each sub-segment of the global neuroendovascular coil market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product type, indication, application, and end user.
Guglielmi Detachable Coils (GDCs)
Matrix Coils
Ruptured Aneurysm
Unruptured Aneurysm
Tumor Surgery
Medical Teaching
Others
Hospitals
Ambulatory Surgical Centers (ASCs)
Stroke Centers
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being Medtronic, Stryker Corporation, DePuy Synthes, Penumbra, Johnson & Johnson Services Inc., Terumo Corporation, Cardinal Health, Boston Scientific Corporation, Cook Medical Incorporated, Balt Extrusion, EndoShape, etc.